Influencer and comedian Evelin Camargo was diagnosed with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) after seeking medical attention for sudden swelling in one of her breasts in late December. The condition, initially mistaken for a possible rupture of the prosthesis, revealed the presence of unusual fluid around the implant.
Laboratory tests, including immunohistochemistry analysis, confirmed the rare type of cancer that originates in cells of the lymphatic system. Evelin promptly shared her experience on social media, aiming to alert other women about the importance of monitoring unexpected changes.
The treatment indicated for the lymphoma, which was restricted to the implant capsule, was surgical removal of the prosthesis. The influencer highlighted that her objective in making the case public is to promote awareness and not generate panic among silicone implant holders.
What is BIA-ALCL lymphoma
Apesar Due to its manifestation in the breast region, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) differs fundamentally from conventional breast cancer. Este is a type of cancer that develops from the cells of the lymphatic system, responsible for the body’s immune defense. The specificity lies in its origin and not in the glandular breast tissue.
Conforme explains Breno Gusmão, member of Comitê Médico of Associação Brasileira of Linfoma and Elas are mainly located in the fibrous capsule that forms naturally around the implant, and not directly in the breast tissue.
Incidence data
BIA-ALCL is recognized as a rare disease, with scientific studies estimating that its occurrence affects, on average, one in every 30,000 women who have undergone breast implant surgery. Variations in incidence depend on multiple factors, such as geography, the specific type of prosthesis used and the time elapsed since surgery. Além In addition, experts warn of the possibility of underreporting, since cases treated surgically are not always registered in official health systems, which can distort real statistics.
Causes and risk factors
The exact etiology of BIA-ALCL is still under intense investigation, but there is a consensus in the medical community about the disease’s most frequent association with textured surface breast implants. Isso does not mean that only these prostheses cause lymphoma, but rather that certain characteristics can increase the risk of its development.
One of the prevailing hypotheses is that the irregular texture of these implants creates an enlarged contact surface that may favor the formation of bacterial biofilms. The presence of these biofilms triggers a continuous and prolonged immune response, keeping the body’s defense system in a constant state of activation for many years.
Essa persistent chronic inflammation is considered one of the main factors that contribute to the malignant transformation of lymphatic cells, as detailed by plastic surgeon Fabiana Catherino. The prolonged inflammatory process, induced by the interaction between the implant and the organism, would be the link for the development of BIA-ALCL, creating an environment conducive to the pathogenesis of cancer.
Diagnosis and warning signs
Early detection of BIA-ALCL is essential for a favorable prognosis, and women with breast implants should be aware of some specific signs that may indicate the presence of the disease. The main one is the late and sudden swelling of one of the breasts, generally caused by the accumulation of fluid (late seroma) around the prosthesis.
Além of swelling, other symptoms deserve immediate attention and in-depth medical investigation. Entre they include persistent pain in the breast region, a recently noticed asymmetry between the breasts, unusual hardness to the touch or the formation of palpable nodules that did not previously exist. Qualquer one of these changes must be promptly evaluated by a specialist for an accurate diagnosis.
Fabiana Catherino, a specialist in the field, reiterates that a late seroma, appearing many years after implant surgery, should never be considered a normal occurrence. Tal condition requires an in-depth investigation to rule out or confirm the diagnosis of BIA-ALCL, with proactiveness in seeking medical evaluation being a decisive factor for the effectiveness of the treatment.
The diagnostic process involves a combination of methods to ensure accuracy:
- Detailed physical examination carried out by a specialist doctor to identify any abnormalities.
- Advanced imaging tests, such as ultrasound and MRI of the breasts, which provide detailed visualization of the prosthesis and surrounding tissues.
- When suspected, a puncture is performed to collect samples of the accumulated fluid or the periprosthetic capsule.
- Specific laboratory analysis, including immunohistochemistry tests, to identify the malignant cells characteristic of lymphoma and differentiate it from other conditions.
Treatment and cure prospects
In most cases of BIA-ALCL, when the disease is diagnosed at an early stage and is restricted to the capsule surrounding the implant, the treatment of choice is complete surgical removal of the prosthesis and the entire adjacent fibrous capsule, in a procedure known as total en bloc capsulectomy. Este method has demonstrated high efficacy and, in these conditions, the prognosis for the patient is generally excellent, with the majority achieving complete cure, underlining the importance of early detection for positive outcomes.
In less common scenarios, where the lymphoma shows signs of spreading to nearby lymph nodes or other organs in the body, the addition of more intensive complementary therapies may be necessary. Isso may include cycles of chemotherapy or immunotherapy to combat the disease on a systemic level, aiming to eradicate malignant cells that may have spread. Contudo, even in these more complex cases, experts emphasize that BIA-ALCL is often a disease with a high potential for cure, emphasizing the importance of rapid and personalized diagnosis and treatment.
Tracking and prevention
Awareness about BIA-ALCL and other risks associated with breast implants has led to the recommendation of proactive medical monitoring and not just reactive treatment of symptoms. Health regulatory agencies in several countries advise women with implants to undergo their first MRI approximately five years after surgery.
Posteriormente, imaging exams such as MRI must be performed at regular intervals, every two or three years, in order to monitor both the integrity of the implant and the condition of the capsule that surrounds it. Este Continuous screening allows early identification of any changes or complications, including the development of BIA-ALCL, and facilitates medical intervention when necessary, ensuring long-term breast health.
Monitoring and crucial information for carriers
The diagnosis of Evelin Camargo reaffirms the importance of an ongoing discussion between healthcare professionals and patients about the longevity and care required by breast implants, which are not considered lifelong devices and require continuous monitoring. Embora Although BIA-ALCL is rare, it is part of a spectrum of risks inherent to the prolonged use of prostheses, which include capsular contracture, rupture, persistent late seromas and the eventual need for revision surgeries, aspects that must be openly discussed. Surgeon Isso inclui a realização de exames de imagem periódicos, conforme as diretrizes estabelecidas pelas agências reguladoras, para uma avaliação completa da prótese e da cápsula circundante. Alterações such as sudden swelling, fluid accumulation, persistent pain or hardening of the breast should be seen as signs from the body that need immediate investigation, without hesitation. Transparent and conscious information about these risks, without generating panic, is vital so that each woman can make informed and proactive decisions about her breast health, understanding that choosing implants implies a commitment to continuous monitoring and management of potential complications throughout life.